126 related articles for article (PubMed ID: 9140865)
1. Evidence for magnesium deficiency in the pathogenesis of bronchopulmonary dysplasia (BPD).
Caddell JL
Magnes Res; 1996 Oct; 9(3):205-16. PubMed ID: 9140865
[TBL] [Abstract][Full Text] [Related]
2. [Magnesium and bronchopulmonary dysplasia].
Fridman E; Linder N
Harefuah; 2013 Mar; 152(3):158-61, 182. PubMed ID: 23713376
[TBL] [Abstract][Full Text] [Related]
3. A review of evidence for a role of magnesium and possibly copper deficiency in necrotizing enterocolitis.
Caddell JL
Magnes Res; 1996 Mar; 9(1):55-66. PubMed ID: 8819095
[TBL] [Abstract][Full Text] [Related]
4. Severity of bronchopulmonary dysplasia and increased risk of feeding desaturation and growth delay in very low birth weight preterm infants.
Wang LY; Luo HJ; Hsieh WS; Hsu CH; Hsu HC; Chen PS; Chiu NC; Lee WT; Jeng SF
Pediatr Pulmonol; 2010 Feb; 45(2):165-73. PubMed ID: 20054861
[TBL] [Abstract][Full Text] [Related]
5. Hospital variation and risk factors for bronchopulmonary dysplasia in a population-based cohort.
Lapcharoensap W; Gage SC; Kan P; Profit J; Shaw GM; Gould JB; Stevenson DK; O'Brodovich H; Lee HC
JAMA Pediatr; 2015 Feb; 169(2):e143676. PubMed ID: 25642906
[TBL] [Abstract][Full Text] [Related]
6. Validation of the National Institutes of Health consensus definition of bronchopulmonary dysplasia.
Ehrenkranz RA; Walsh MC; Vohr BR; Jobe AH; Wright LL; Fanaroff AA; Wrage LA; Poole K;
Pediatrics; 2005 Dec; 116(6):1353-60. PubMed ID: 16322158
[TBL] [Abstract][Full Text] [Related]
7. Bronchopulmonary dysplasia and inflammatory biomarkers in the premature neonate.
Bose CL; Dammann CE; Laughon MM
Arch Dis Child Fetal Neonatal Ed; 2008 Nov; 93(6):F455-61. PubMed ID: 18676410
[TBL] [Abstract][Full Text] [Related]
8. Respiratory burst activity in bronchopulmonary dysplasia and changes with dexamethasone.
Ballabh P; Simm M; Kumari J; Califano C; Aghai Z; Laborada G; Sison C; Cunningham-Rundles S
Pediatr Pulmonol; 2003 May; 35(5):392-9. PubMed ID: 12687597
[TBL] [Abstract][Full Text] [Related]
9. Evidence of early adrenal insufficiency in babies who develop bronchopulmonary dysplasia.
Watterberg KL; Scott SM
Pediatrics; 1995 Jan; 95(1):120-5. PubMed ID: 7770288
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms initiating lung injury in the preterm.
Jobe AH; Ikegami M
Early Hum Dev; 1998 Nov; 53(1):81-94. PubMed ID: 10193929
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-4 and 13 concentrations in infants at risk to develop Bronchopulmonary Dysplasia.
Baier RJ; Loggins J; Kruger TE
BMC Pediatr; 2003 Aug; 3():8. PubMed ID: 12925236
[TBL] [Abstract][Full Text] [Related]
12. Inflammatory markers in intrauterine and fetal blood and cerebrospinal fluid compartments are associated with adverse pulmonary and neurologic outcomes in preterm infants.
Viscardi RM; Muhumuza CK; Rodriguez A; Fairchild KD; Sun CC; Gross GW; Campbell AB; Wilson PD; Hester L; Hasday JD
Pediatr Res; 2004 Jun; 55(6):1009-17. PubMed ID: 15155869
[TBL] [Abstract][Full Text] [Related]
13. Value of serum and bronchoalveolar fluid lavage pro- and anti-inflammatory cytokine levels for predicting bronchopulmonary dysplasia in premature infants.
Köksal N; Kayik B; Çetinkaya M; Özkan H; Budak F; Kiliç Ş; Canitez Y; Oral B
Eur Cytokine Netw; 2012 Jun; 23(2):29-35. PubMed ID: 22591771
[TBL] [Abstract][Full Text] [Related]
14. Bubble nasal CPAP, early surfactant treatment, and rapid extubation are associated with decreased incidence of bronchopulmonary dysplasia in very-low-birth-weight newborns: efficacy and safety considerations.
Friedman CA; Menchaca RC; Baker MC; Rivas CK; Laberge RN; Rios EH; Haider SH; Romero EJ; Eason EB; Fraley JK; Woldesenbet M
Respir Care; 2013 Jul; 58(7):1134-42. PubMed ID: 23106970
[TBL] [Abstract][Full Text] [Related]
15. Pulmonary outcome in former preterm, very low birth weight children with bronchopulmonary dysplasia: a case-control follow-up at school age.
Vom Hove M; Prenzel F; Uhlig HH; Robel-Tillig E
J Pediatr; 2014 Jan; 164(1):40-45.e4. PubMed ID: 24055328
[TBL] [Abstract][Full Text] [Related]
16. Bronchopulmonary dysplasia in very low birth weight infants is associated with prolonged hospital stay.
Klinger G; Sirota L; Lusky A; Reichman B
J Perinatol; 2006 Oct; 26(10):640-4. PubMed ID: 17006525
[TBL] [Abstract][Full Text] [Related]
17. Association between fluid intake and weight loss during the first ten days of life and risk of bronchopulmonary dysplasia in extremely low birth weight infants.
Oh W; Poindexter BB; Perritt R; Lemons JA; Bauer CR; Ehrenkranz RA; Stoll BJ; Poole K; Wright LL;
J Pediatr; 2005 Dec; 147(6):786-90. PubMed ID: 16356432
[TBL] [Abstract][Full Text] [Related]
18. Increase of interleukin-6 in tracheal aspirate at birth: a predictor of subsequent bronchopulmonary dysplasia in preterm infants.
Choi CW; Kim BI; Kim HS; Park JD; Choi JH; Son DW
Acta Paediatr; 2006 Jan; 95(1):38-43. PubMed ID: 16373294
[TBL] [Abstract][Full Text] [Related]
19. Association of pulmonary inflammation and increased microvascular permeability during the development of bronchopulmonary dysplasia: a sequential analysis of inflammatory mediators in respiratory fluids of high-risk preterm neonates.
Groneck P; Götze-Speer B; Oppermann M; Eiffert H; Speer CP
Pediatrics; 1994 May; 93(5):712-8. PubMed ID: 8165067
[TBL] [Abstract][Full Text] [Related]
20. Early postnatal additional high-dose oral vitamin A supplementation versus placebo for 28 days for preventing bronchopulmonary dysplasia or death in extremely low birth weight infants.
Meyer S; Gortner L;
Neonatology; 2014; 105(3):182-8. PubMed ID: 24434948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
